Ali Behbahani Transaction History

Date Transaction Value Shares Traded Form
Apr 22 2024
BUY
Grant, award, or other acquisition
$999,992 $56.0 p/Share
17,857
Nov 03 2023
BUY
Grant, award, or other acquisition
-
1,072,936

Also insider at

CRSP
CRISPR Therapeutics AG Healthcare
RGLS
Regulus Therapeutics Inc. Healthcare
MRKR
Marker Therapeutics, Inc. Healthcare
BDTX
Black Diamond Therapeutics, Inc. Healthcare
OYST
Oyster Point Pharma, Inc. Healthcare
NKTX
Nkarta, Inc. Healthcare
GLUE
Monte Rosa Therapeutics, Inc. Healthcare
BHG
Bright Health Group Inc. Healthcare
CVRX
CVRx, Inc. Healthcare
ADAP
Adaptimmune Therapeutics PLC Healthcare
GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
TRVI
Trevi Therapeutics, Inc. Healthcare
UTRS
MINERVA SURGICAL INC Healthcare
MTCR
Metacrine, Inc. Healthcare
AKUS
Akouos, Inc. Healthcare
ACLX
Arcellx, Inc. Healthcare
MIRM
Mirum Pharmaceuticals, Inc. Healthcare
SVRA
Savara Inc Healthcare
MBX
MBX Biosciences, Inc.
AB

Ali Behbahani

Timonium, MD

Track Institutional and Insider Activities on FREQ

Follow Frequency Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FREQ shares.

Notify only if

Insider Trading

Get notified when an Frequency Therapeutics, Inc. insider buys or sells FREQ shares.

Notify only if

News

Receive news related to Frequency Therapeutics, Inc.

Track Activities on FREQ